1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEXIMMUNE INC

Neximmune Inc

XNAS: NEXI

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Neximmune Inc is on 27 May 2025 for the purpose of NexImmune Inc First Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Neximmune Inc

The latest disclosure was made by Kristi Jones in Neximmune Inc where a trade of 1 Series A Preferred Stock, par value $0.0001 per share done was reported to US exchanges on June 11, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kristi Jones Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Jun 2024 1 1 - 0 Series A Preferred Stock, par value $0.0001 per share
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 44,983 44,983 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 44,983 44,983 - - Stock Option (right to buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 44,983 44,983 - - Stock Option (right to buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 44,983 44,983 - - Stock Option (right to buy)
Grant Verstandig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 44,983 44,983 - - Stock Option (right to buy)
Leena Gandhi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jul 2023 44,983 44,983 - - Stock Option (right to buy)
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 19,113 19,113 - - Stock Option (right to buy)
Sol J. Barer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 61,678 0 - - Stock Option (right to buy)
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 155,900 155,900 - - Stock Option (right to buy)
Sol J. Barer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 155,900 0 - - Stock Option (right to buy)
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 61,678 61,678 - - Stock Option (right to buy)
Sol J. Barer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 19,113 0 - - Stock Option (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 61,678 0 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 3,856 3,856 - - Stock Option (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 3,856 0 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 23,122 23,122 - - Stock Option (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 23,122 0 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 9,556 9,556 - - Stock Option (right to buy)
Alan S. Roemer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 9,556 0 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 61,678 61,678 - - Stock Option (right to buy)
Timothy Bertram Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 61,678 0 - - Stock Option (right to buy)
Timothy Bertram Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 23,122 0 - - Stock Option (right to buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 23,122 23,122 - - Stock Option (right to buy)
Timothy Bertram Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 12,634 12,634 - - Stock Option (right to buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 12,634 12,634 - - Stock Option (right to buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 9,556 9,556 - - Stock Option (right to buy)
Timothy Bertram Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 9,556 0 - - Stock Option (right to buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 61,678 61,678 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 78,100 0 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 13,727 13,727 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 89,222 89,222 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 102,949 0 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 10,267 10,267 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 18,720 18,720 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 28,987 0 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 50,440 50,440 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 27,660 27,660 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 89,100 89,100 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 15,743 15,743 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 300,000 30,000 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 456,000 0 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 161,500 161,500 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 294,500 294,500 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 84,207 0 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 54,383 54,383 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 29,824 29,824 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 18,824 0 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 18,824 18,824 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 24,499 0 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 24,499 24,499 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 3,715 0 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 3,715 3,715 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 88,156 0 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 88,156 88,156 - - Stock Option (right to buy)
Kristi Jones Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 15,743 0 - - Stock Option (right to buy)
Paul D’Angio Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 9,556 0 - - Stock Option (right to buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 61,678 61,678 - - Stock Option (right to buy)
Paul D’Angio Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 61,678 0 - - Stock Option (right to buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 23,122 23,122 - - Stock Option (right to buy)
Paul D’Angio Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 12,634 0 - - Stock Option (right to buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 12,634 12,634 - - Stock Option (right to buy)
Paul D’Angio Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 23,122 0 - - Stock Option (right to buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 9,556 9,556 - - Stock Option (right to buy)
Grant Verstandig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 5,430 5,430 - - Stock Option (right to buy)
Grant Verstandig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 61,678 61,678 - - Stock Option (right to buy)
Grant Verstandig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 39,096 0 - - Stock Option (right to buy)
Grant Verstandig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 33,666 33,666 - - Stock Option (right to buy)
Grant Verstandig Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 61,678 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 31,948 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 7,050 7,050 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 15,793 15,793 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 47,379 47,379 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 15,793 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 47,379 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 38,750 38,750 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 21,250 21,250 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 60,000 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 81,100 81,100 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 19,905 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 12,855 12,855 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 115,051 115,051 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 115,051 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 4,755 4,755 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 4,755 0 - - Stock Option (right to buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 31,948 31,948 - - Stock Option (right to buy)
Leena Gandhi Director Sale or transfer of securities back to the company at price $ 0.00 per share. 04 Apr 2023 80,947 0 - - Stock Option (right to buy)
Leena Gandhi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 44,971 44,971 - - Stock Option (right to buy)
Leena Gandhi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 35,976 35,976 - - Stock Option (right to buy)
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 0.41 per share. 30 Mar 2023 400,000 2,217,814 - 0.4 164,120 Common Stock
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Nov 2022 296,700 369,778 - 0 Common Stock
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Nov 2022 125,200 186,969 - 0 Common Stock
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Nov 2022 126,100 134,023 - 0 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 0.48 per share. 16 Nov 2022 75,000 1,817,814 - 0.5 35,918 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 0.48 per share. 16 Nov 2022 125,000 1,742,814 - 0.5 60,300 Common Stock
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 61,678 61,678 - - Stock Option (Right to Buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 61,678 61,678 - - Stock Option (Right to Buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 61,678 61,678 - - Stock Option (Right to Buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 61,678 61,678 - - Stock Option (Right to Buy)
Grant Verstandig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 61,678 61,678 - - Stock Option (Right to Buy)
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 2.14 per share. 03 Jun 2022 25,000 1,078,619 - 2.1 53,538 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 2.22 per share. 03 Jun 2022 15,000 1,053,619 - 2.2 33,374 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 2.28 per share. 03 Jun 2022 26,876 1,105,495 - 2.3 61,385 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.22 per share. 31 May 2022 20,720 1,617,814 - 2.2 46,100 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.19 per share. 31 May 2022 39,280 1,557,094 - 2.2 85,894 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.35 per share. 31 May 2022 40,000 1,597,094 - 2.4 94,160 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 2.23 per share. 31 May 2022 47,900 1,038,619 - 2.2 106,683 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 2.11 per share. 31 May 2022 45,024 950,519 - 2.1 95,118 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 2.38 per share. 31 May 2022 40,200 990,719 - 2.4 95,760 Common Stock
Leena Gandhi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 May 2022 80,947 80,947 - - Stock Option (Right to Buy)
Jerome Bernard Zeldis Executive VP of Research & Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 80,100 80,100 - - Stock Option (Right to Buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 78,100 78,100 - - Stock Option (Right to Buy)
Kristi Jones Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 456,000 456,000 - - Stock Option (Right to Buy)
Robert Knight Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 48,000 48,000 - - Stock Options (Right to Buy)
Mathias Oelke Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 60,000 60,000 - - Stock Option (Right to Buy)
Kristi Jones Director, President and CEO Purchase of securities on an exchange or from another person at price $ 3.74 per share. 29 Mar 2022 10,000 73,078 - 3.7 37,400 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 4.14 per share. 24 Mar 2022 131,622 886,512 - 4.1 544,915 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 3.76 per share. 24 Mar 2022 18,983 905,495 - 3.8 71,376 Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 3.35 per share. 24 Mar 2022 39,995 754,890 - 3.3 133,983 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.67 per share. 23 Mar 2022 10,000 1,517,814 - 2.7 26,653 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.41 per share. 22 Mar 2022 30,000 1,507,814 - 2.4 72,300 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.14 per share. 21 Mar 2022 30,000 1,477,814 - 2.1 64,080 Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 2.11 per share. 18 Mar 2022 30,000 1,447,814 - 2.1 63,210 Common Stock
Sol J. Barer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 21 Dec 2021 50,000 1,417,814 - 5.2 258,500 Common Stock
Sol J. Barer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 50,000 155,900 - - Stock Option (right to buy)
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share. 21 Dec 2021 42,389 195,641 - 4.3 182,697 Common Stock
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.58 per share. 21 Dec 2021 12,634 153,252 - 2.6 32,596 Common Stock
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. 21 Dec 2021 12,634 140,618 - 2.4 30,574 Common Stock
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 42,389 3,856 - - Stock Option (right to buy)
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 12,634 0 - - Stock Option (right to buy)
Alan S. Roemer Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2021 12,634 0 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jul 2021 3,432 102,949 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 08 Jul 2021 3,432 61,770 - 5.2 17,743 Common Stock
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jun 2021 3,432 106,381 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 08 Jun 2021 3,432 58,338 - 5.2 17,743 Common Stock
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 08 Apr 2021 3,432 54,906 - 5.2 17,743 Common Stock
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Apr 2021 3,432 109,813 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Apr 2021 3,432 113,245 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 08 Apr 2021 3,432 51,474 - 5.2 17,743 Common Stock
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2021 3,432 116,677 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 10 Mar 2021 3,432 48,042 - 5.2 17,743 Common Stock
Sol J. Barer Director 17 Feb 2021 894,036 894,036 - - Common Stock
Sol J. Barer Director 17 Feb 2021 217,570 0 - - Series A Preferred Stock
Sol J. Barer Director 17 Feb 2021 82,204 0 - - Series A3 Preferred Stock
Sol J. Barer Director 17 Feb 2021 164,408 0 - - Series A2 Preferred Stock
Sol J. Barer Director 17 Feb 2021 894,036 0 - - Series A Preferred Stock
Sol J. Barer Director 17 Feb 2021 800,182 0 - - Series A Preferred Stock
Sol J. Barer Director 17 Feb 2021 217,570 346,577 - - Common Stock
Sol J. Barer Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 17 Feb 2021 60,000 1,538,013 - 17 1,020,000 Common Stock
Sol J. Barer Director 17 Feb 2021 337,365 1,478,013 - - Common Stock
Sol J. Barer Director 17 Feb 2021 82,204 1,140,648 - - Common Stock
Sol J. Barer Director 17 Feb 2021 164,408 1,058,444 - - Common Stock
Sol J. Barer Director 17 Feb 2021 800,182 1,367,814 - - Common Stock
Alan S. Roemer Director 17 Feb 2021 26,590 115,716 - - Common Stock
Alan S. Roemer Director 17 Feb 2021 12,268 127,984 - - Common Stock
Alan S. Roemer Director 17 Feb 2021 85,016 0 - - Series A Preferred Stock
Alan S. Roemer Director 17 Feb 2021 26,590 0 - - Series A3 Preferred Stock
Alan S. Roemer Director 17 Feb 2021 4,110 0 - - Series A2 Preferred Stock
Alan S. Roemer Director 17 Feb 2021 85,016 85,016 - - Common Stock
Alan S. Roemer Director 17 Feb 2021 4,110 89,126 - - Common Stock
Jerome Bernard Zeldis Executive VP of Research & Dev Purchase of securities on an exchange or from another person at price $ 17.00 per share. 17 Feb 2021 5,882 5,882 - 17 99,994 Common Stock
Timothy Bertram Director 17 Feb 2021 16,440 0 - - Series A3 Stock
Timothy Bertram Director 17 Feb 2021 10,344 0 - - Series A2 Preferred Stock
Timothy Bertram Director 17 Feb 2021 44,965 0 - - Series A Preferred Stock
Timothy Bertram Director 17 Feb 2021 16,440 78,199 - - Common Stock
Timothy Bertram Director 17 Feb 2021 10,344 61,759 - - Common Stock
Timothy Bertram Director 17 Feb 2021 44,965 51,415 - - Common Stock
Scott Carmer Director, President and CEO 17 Feb 2021 7,058 7,058 - - Common Stock
Scott Carmer Director, President and CEO 17 Feb 2021 7,058 0 - - Series A Preferred Stock
Kristi Jones Chief Operating Officer 17 Feb 2021 14,738 62,167 - - Common Stock
Kristi Jones Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 17.00 per share. 17 Feb 2021 911 63,078 - 17 15,487 Common Stock
Kristi Jones Chief Operating Officer 17 Feb 2021 14,738 0 - - Series A Preferred Stock
Paul D’Angio Director 17 Feb 2021 19,627 0 - - Series A Preferred Stock
Paul D’Angio Director 17 Feb 2021 19,627 19,627 - - Common Stock
Paul D’Angio Director 17 Feb 2021 4,110 23,737 - - Common Stock
Paul D’Angio Director 17 Feb 2021 4,110 27,847 - - Common Stock
Paul D’Angio Director 17 Feb 2021 4,110 0 - - Series A2 Preferred Stock
Paul D’Angio Director 17 Feb 2021 4,110 0 - - Series A3 Preferred Stock
Grant Verstandig Director 17 Feb 2021 539,895 539,895 - - Common Stock
Grant Verstandig Director Purchase of securities on an exchange or from another person at price $ 17.00 per share. 17 Feb 2021 175,000 714,895 - 17 2,975,000 Common Stock
Sol J. Barer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 19,113 225,013 - - Stock Option (right to buy)
Alan S. Roemer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 9,556 104,191 - - Stock Option (right to buy)
Jerome Bernard Zeldis Executive VP of Research & Dev Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 351,016 351,016 - - Stock Option (right to buy)
Timothy Bertram Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 9,556 45,312 - - Stock Option (right to buy)
Scott Carmer Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 306,842 770,923 - - Stock Option (right to buy)
John Trainer Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 28,987 149,096 - - Stock Option (right to buy)
Kristi Jones Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 84,207 235,144 - - Stock Option (right to buy)
Robert Knight Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 210,609 210,609 - - Stock Option (right to buy)
Paul D’Angio Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 9,556 45,312 - - Stock Option (right to buy)
Grant Verstandig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 39,096 39,096 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters